Read More at Fight Aging! Merging the non-profits SENS Research Foundation and Lifespan.io is one of those ideas that makes a lot of sense in hindsight. SENS Research Foundation is research focused and very much interested in expanding into patient advocacy, as it depends on philanthropic funding. Lifespan.io is a patient advocacy organization that is very much interested into expanding into helping to advance the science of aging and clinical trials for therapies of aging. They complement one another, and may well produce greater gains as one organization than as two. Lifespan.io, renowned for its unwavering advocacy for longevity and responsible journalism, is joining hands with SENS Research Foundation, a trailblazer in longevity-focused research and a pioneer of the damage-repair approach to combating aging. Together, these organizations bring a formidable quarter-century of combined expertise to the table. Their collaborative efforts…
Aubrey de Grey Establishes the Longevity Escape Velocity Foundation
Read More at Fight Aging! Aubrey de Grey, co-founder of the Methuselah Foundation and later the SENS Research Foundation (SRF), funding the latter organization with $13M of his own resources to add to the donations of philanthropists, has over the past year separated from the SRF, for reasons that I intend to neither discuss nor have a public opinion on. Per his presentation at the recent Longevity Summit Dublin, he has now founded the Longevity Escape Velocity (LEV) Foundation in collaboration with the Ichor Life Sciences principals to continue to bring funding into the programs that he believes need to happen in order to unblock important lines of research and development leading to rejuvenation therapies. It is quite clearly the case that we wouldn’t be as far advanced as we are today without the past twenty years of patient advocacy,…
SENS Research Foundation Annual Reports for 2022
Read More at Fight Aging! The SENS Research Foundation has published its annual reports for 2022, for those interested. SENS, the Strategies for Engineered Negligible Senescence, is both (a) a laundry list of forms of cell and tissue damage that cause aging, with supporting evidence from the past century of scientific research into aging, and (b) a laundry list methods of intervention that should produce rejuvenation. Aging is damage accumulation, and rejuvenation is repair of that damage. Funding for SENS programs, and initiatives to produce therapies based on the SENS view of damage repair, remain as relevant as ever. In fact, even more relevant now than was the case in the early 2000s, given the extensive evidence gathered over the past decade to support the SENS view on the role of senescent cells in aging. The view that accumulation of…
The Hevolution Foundation Plans to Fund Aging Research and the Longevity Industry
Read More at Fight Aging! Funding for aging research and the development of therapies to treat aging as a medical condition used to be hard to come by. It was a fringe field of medicine. But slow years of bootstrapping incremental progress – hard work, patient advocacy, and philanthropy – eventually led to technology demonstrations, such as the rejuvenation of mice with senolytic therapies, that convinced the first large sources of funding to enter the field. That produced further progress, and the start of a longevity industry, enough to convince deeper pockets to participate. That in turn made slowing and reversing aging a viable investment for a growing number of sizable sources of wealth. History teaches to be cautious about newly announced large investments in the field of aging and longevity, however. Calico launched with much fanfare, hundreds of millions…